SciSparc (SPRC) Long-Term Debt Issuances (2016 - 2018)
SciSparc (SPRC) posted Long-Term Debt Issuances of $3.6 million for Q4 2018, up 321.91% sequentially from -$1.6 million in Q3 2018, and up 3936.17% YoY from $89342.1 in Q4 2017.
SciSparc (SPRC) Long-Term Debt Issuances (2016 - 2018) Analysis & Trends
SciSparc has reported Long-Term Debt Issuances for 3 years, with the latest figure at $3.6 million in Q4 2018.
- Quarterly Long-Term Debt Issuances rose 3936.17% year-over-year to $3.6 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $1.4 million (down 89.49% YoY) and the FY2025 annual result came in at $4.0 million, down 36.21% from the prior year.
- Long-Term Debt Issuances rose to $3.6 million in Q4 2018 per SPRC's latest filing, from -$1.6 million in the prior quarter.
- Over five years, Long-Term Debt Issuances peaked at $11.2 million in Q1 2017 and troughed at -$1.6 million in Q3 2018.
- A 3-year average of $2.0 million and a median of $613000.0 in 2016 frame the typical range for Long-Term Debt Issuances.
- The widest YoY moves for Long-Term Debt Issuances: up 3936.17% in 2018, down 1454.17% in 2018.
- Over 3 years, Long-Term Debt Issuances stood at $1.1 million in 2016, then sank by 108.5% to -$94000.0 in 2017, then jumped by 3936.17% to $3.6 million in 2018.
- According to Business Quant data, Long-Term Debt Issuances over the past three periods registered $3.6 million, -$1.6 million, and -$500000.0 for Q4 2018, Q3 2018, and Q2 2018 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | SciSparc | 831,418.60 | 831,418.60 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 3.61 Mn |
| Dec 31, 2018 | 3.61 Mn |
| Sep 30, 2018 | -1.63 Mn |
| Sep 30, 2018 | -1.63 Mn |
| Jun 30, 2018 | -500,000.00 |
| Jun 30, 2018 | -500,000.00 |
| Dec 31, 2017 | -94,000.00 |
| Dec 31, 2017 | -94,000.00 |
| Sep 30, 2017 | 120,000.00 |
| Sep 30, 2017 | 120,000.00 |
| Jun 30, 2017 | 1.94 Mn |
| Jun 30, 2017 | 1.94 Mn |
| Mar 31, 2017 | 11.22 Mn |
| Mar 31, 2017 | 11.22 Mn |
| Sep 30, 2016 | 1.11 Mn |
| Sep 30, 2016 | 1.11 Mn |